Rilpivirine long-acting
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rilpivirine long-acting, covering 2020-06-11 to 2020-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults [Phase 3]